Table 3.

Efficacy of ASAQ and AL as first-line and second-line treatments

	First treated malaria episode	≥Second treated malaria episode
ASAQ
ACPR, N (%)	59 (98.3)	37 (94.9)	RR = 1.04 (0.96–1.12)
Recrudescence, N (%)	1 (1.7)	2 (5.1)	P = 0.3
New infection	3	5
Lost-to-follow-up	15	7
AL
ACPR, N (%)	69 (94.5)	37 (100.0)	RR = 0.95 (0.89–1.00)
Recrudescence, N (%)	4 (5.5)	0	P = 0.19
New infection	4	4
Lost-to-follow-up	10	5
	RR = 1.04 (0.98–1.11), P = 0.2	RR = 0.95 (0.88–1.02), P = 0.26

ASAQ artesunate-amodiaquine, AL artemether-lumefantrine, ACPR adequate clinical and parasitological response